Menopausal hormone therapy and breast cancer risk. the cardiological point of view

We felt the compulsory and urgent need to highlight some peculiar risk factors' prevention in women, on the basis of evidence that certain typical or exclusive conditions in women could alter their personal risk, clinical presentation, therapeutic response and prognosis in cardiovascular diseases. In a recent metanalysis, hormone replacement therapy (HRT) has been connected to an increased risk for breast cancer in postmenopausal women. So, we are worried about the possible future, incorrect underuse of HRT to avoid breast cancer in women with high cardiovascular risk.We would like to stimulate a proper awareness in clinicians, in order to elite the need of a responsible, appropriate and patient-customized approach to personal risk factors, undertaking all possible prevention strategies in order to avoid future damaging and expensive diseases.